Clinical aspects of percutaneous poisoning by the chemical warfare agent VX: Effects of application site and decontamination

Military Medicine

Volumn 169, Issue 11, 2004, Pages 856-862

  Hamilton, Murray G ^a   Hill, Ira ^b   Conley, John ^b   Sawyer, Thomas W ^a   Caneva, Duane C ^c   Lundy, Paul M ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^b Kinchyle Enterprises Inc   (Canada)

^c NAVAL SURFACE WARFARE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL WARFARE AGENT; METHYLPHOSPHONOTHIOIC ACID S (2 DIISOPROPYLAMINOETHYL) O ETHYL ESTER; CHOLINESTERASE; MACROGOL DERIVATIVE; PHOSPHOROTHIOIC ACID DERIVATIVE;

APNEA; ARTICLE; CAPNOGRAPHY; CHEMICAL WARFARE; CONTROLLED STUDY; DATA ANALYSIS; DEATH; MALE; NONHUMAN; PULSE OXIMETRY; SKIN DECONTAMINATION; SWINE; VENOUS BLOOD; ANIMAL; ANIMAL MODEL; BLOOD; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EAR; HUMAN; INTRADERMAL DRUG ADMINISTRATION; PATHOLOGY; PHYSIOLOGY; SKIN; SKIN ABSORPTION; TIME; TOXICITY TESTING; WASTE MANAGEMENT;

ADMINISTRATION, CUTANEOUS; ANIMALS; APNEA; CHEMICAL WARFARE AGENTS; CHOLINESTERASES; DECONTAMINATION; EAR; HUMANS; MALE; MODELS, ANIMAL; ORGANOTHIOPHOSPHORUS COMPOUNDS; POLYETHYLENE GLYCOLS; SKIN; SKIN ABSORPTION; SUS SCROFA; TIME FACTORS; TOXICITY TESTS;

EID: 16644373376     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.7205/MILMED.169.11.856     Document Type: Article

References (28)

1. Morita H, Yanagisawa N, Nakajima T, et al: Sarin poisoning in Matsumoto, Japan. Lancet 1995; 346: 290-3.
2. Suzuki J, Kohno T, Tsukagosi M, Furuhata T, Yamazaki K: Eighteen cases exposed to sarin in Matsumoto, Japan. Intern Med 1997; 36; 466-70.
3. Okudera H, Monta H, Iwashita T, et al: Unexpected nerve gas exposure in the city of Matsumoto; report of rescue activity in the first sarin gas terrorism. Am J Emerg Med 1997; 15: 527-8.
4. Sekijima Y, Morita H, Yanagisawa N: Follow-up of sarin poisoning in Matsumoto. Ann Intern Med 1997; 127: 1042.
5. Suzuki T, Morita H, Ono K, Maekawa K, Nagai R, Yazaki Y: Sarin poisoning in Tokyo subway. Lancet 1995; 345: 980.
6. Nozaki H, Aikawa N, Shinozawa Y, et al: Sarin poisoning in Tokyo subway. Lancet 1995; 345: 980-1.
7. Masuda N, Takatsu M, Morinari H, Ozawa T: Sarin poisoning in Tokyo subway. Lancet 1995; 345: 1446.
8. Nozaki H, Aikawa N: Sarin poisoning in Tokyo subway. Lancet 1995; 345: 1446-7.
9. Yokoyama K, Ogura Y, Kishimoto M, et al: Blood purification for severe sarin poisoning after the Tokyo subway attack. JAMA 1995; 274: 379.
10. Hatta K, Miura Y, Asukai N, Hamabe Y: Amnesia from sarin poisoning. Lancet 1996; 347: 1343.
11. Yokoyama K, Yamada A, Mimura N: Clinical profiles of patients with sarin poisoning after the Tokyo subway attack. Am J Med 1996; 100: 586.
12. Okumura T, Takasu N, Ishimatsu S, et al: Report on 640 victims of the Tokyo subway sarin attack. Ann Emerg Med 1996; 28: 129-35.
13. Anonymous: Global Proliferation of Weapons of Mass Destruction: A Case Study of Aum Shinrikyo. IV. Senate Government Affairs Permanent Subcommittee on Investigations, 1995. Available at http://www.fas.org/irp/congress/1995_rpt/ aum/part04.htm; accessed October 31, 1995.
14. Nozaki H, Aikawa N, Fujishima S, et al: A case of VX poisoning and the difference from sarin. Lancet 1995; 346: 698-9.
15. Sidell FR. Nerve Agents. In: Textbook of Military Medicine: Medical Aspects of Chemical and Biological Warfare, pp 129-80. Edited by Sidell FR, Takafuji. ET Franz DR. Washington, DC. Office of the Surgeon General, 1997.
16. Sim VM: Variation of different intact human skin sites to the penetration of VX. Technical Report CRDLR 3122, U.S. Army Chemical Research and Development Laboratory, Army Chemical Center, MD, February 1962.
17. Sim VM, Stubbs JL: Percutaneous studies in man. Technical Report CRDLR 3015, U.S. Army Chemical Research and Development Center, MD, February 1960.
18. Duncan EJ, Brown A, Lundy P, et al: Site-specific percutaneous absorption of methyl salicylate and VX in domestic swine. J Appl Toxicol 2002; 22: 141-8.
19. Monteiro-Riviere NA, Riviere J: The pig as a model for cutaneous pharmacology and toxicology research. In: Advances in Swine in Biomedical Research, Vol 2, pp 425-58. Edited by Tumbelson ME, Schook LB, New York, Plenum Press. 1996,
20. Goransson-Nyberg A, Cassel G, Jeneskog T, et al: Treatment of organophosphate poisoning in pigs: antidote administration by a new binary autoinjector. Arch Toxicol 1995; 70: 20-7.
21. Duncan EJ, Conley JD, Grychowski KD, et al: A comparison of the effects of sarin and succinylcholine on respiratory parameters in anesthetized domestic swine. Milit Med 2001; 166: 322-7.
22. Johnson CD, Russell RL: A rapid, simple radiometric assay for cholinesterase, suitable for multiple determinations. Anal Biochem 1975; 64: 229-38.
23. Marini JJ: Lung mechanics determinations at the bedside: instrumentation and clinical application. Respir Care 1990; 35: 669-93.
24. Whitlaw WA, Derenne JP: Airway occlusion pressure. J Appl Physiol 1993; 74: 1475-83.
25. Chilcott RP, Dalton CH, Hill I, et al: Skin absorption of the nerve agent VX. Part I. In vivo studies using the domestic white pig. Biosci Rev 2002, Abstract 1473.
26. Yang Y-C: Chemical detoxification of nerve agent VX. Acc Chem Res 1999; 32: 109-15.
27. Sawyer TW, Parker D, Thomas N, Weiss MT, Bide RW: Efficacy of an oximate-based skin decontaminant against organophosphate nerve agents determined in VITO and in vitro. Toxicology 1991; 67: 267-77.
28. Nozaki H, Hori S, Shinozawa Y, et al: Secondary exposure of medical staff to sarin vapor in the emergency room. Intensive Care Med 1995; 21: 1032-5.